Journal of Thrombosis and Thrombolysis

, Volume 36, Issue 4, pp 514–526 | Cite as

Bleeding risk assessment using whole blood impedance aggregometry and rotational thromboelastometry in patients following cardiac surgery

  • Mate Petricevic
  • Bojan Biocina
  • Davor Milicic
  • Sanja Konosic
  • Lucija Svetina
  • Ante Lekić
  • Boris Zdilar
  • Ivan Burcar
  • Milan Milosevic
  • Rifat Brahimaj
  • Jure Samardzic
  • Hrvoje Gasparovic
Article

Abstract

Excessive bleeding after cardiopulmonary bypass (CPB) is risk factor for adverse outcomes after elective cardiac surgery (ECS). Differentiating between patients who bleed due to surgical issues and those whose excessive chest tube output (CTO) is due to coagulopathy, remains challenging. Bedside suitable tests to identify hemostatic disturbances and predict excessive bleeding are desirable. The study sought to evaluate prediction of excessive bleeding after ECS using two bedside suitable devices for platelet function and viscoelastic blood clot properties assessment. We enrolled 148 patients (105 male and 43 female) undergoing ECS in a prospective observational study. Patients were characterized as bleeders if their 24 h CTO exceeded the 75th percentile of distribution. Multiple electrode aggregometry (MEA, with ASPI, ADP and the TRAP test) and rotational thromboelastometry (TEM, with ExTEM, HepTEM and FibTEM test), were performed at three time points: preoperatively (T1), during CPB (T2), and after protamine administration (T3). The primary endpoint was CTO and the secondary endpoint was administration of blood products, 30-day and 1 year mortality. The best predictors of increased bleeding tendency were the tests performed after protamine administration (T3). At T3, patients characterized as bleeders had significantly lower MEA ASPI (median, 14 vs. 27 AUC, p = 0.004) and ADP test values (median, 22 vs. 41 AUC, p = 0.002) as well as TEM values expressed in maximum clot firmness after 30 min (MCF 30) for ExTEM (53 vs. 56 mm, p = 0.005), HepTEM (48 vs. 52 mm, p = 0.003) and FibTEM (8 vs. 11 mm, p < 0.001) test. 24 h CTO inversely correlated with both the MEA (ASPI test: r = −0.236, p = 0.004; ADP test: r = −0.299, p < 0.001), and TEM MCF 30 (ExTEM: r = −0.295, p < 0.001; HepTEM: −0.329, p < 0.001; FibTEM: −0.377, p < 0.001) test values. Our study showed that MEA and TEM are useful methods for prediction of excessive bleeding after ECS. In order to prevent excessive postoperative CTO, hemostatic interventions with timely and targeted blood component therapy according to MEA and TEM results should be considered.

Keywords

Multiple electrode aggregometry Rotational thromboelastometry Cardiac surgery Bleeding risk Transfusion 

References

  1. 1.
    Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussieres JS, Cote D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358:2319–2331PubMedCrossRefGoogle Scholar
  2. 2.
    Woodman RC, Harker LA (1990) Bleeding complications associated with cardiopulmonary bypass. Blood 76:1680–1697PubMedGoogle Scholar
  3. 3.
    Dixon B, Santamaria JD, Reid D, Collins M, Rechnitzer T, Newcomb AE, Nixon I, Yii M, Rosalion A, Campbell DJ (2012) The association of blood transfusion with mortality after cardiac surgery: cause or confounding? Transfusion. doi:10.1111/j.1537-2995.2012.03697.x PubMedGoogle Scholar
  4. 4.
    Practice Guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy (1996) Anesthesiology 84:732–747Google Scholar
  5. 5.
    Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, Lewis WF, Notari EP, Petersen LR (1995) Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 333:1721–1725PubMedCrossRefGoogle Scholar
  6. 6.
    Tremolada F, Chiappetta F, Noventa F, Valfre C, Ongaro G, Realdi G (1983) Prospective study of posttransfusion hepatitis in cardiac surgery patients receiving only blood or also blood products. Vox Sang 44:25–30PubMedCrossRefGoogle Scholar
  7. 7.
    Fries D, Streif W, Haas T, Kuhbacher G (2004) Dilutional coagulopathy, an underestimated problem? Anasthesiol Intensivmed Notfallmed Schmerzther 39:745–750PubMedCrossRefGoogle Scholar
  8. 8.
    Edmunds LH Jr, Ellison N, Colman RW, Niewiarowski S, Rao AK, Addonizio VP Jr, Stephenson LW, Edie RN (1982) Platelet function during cardiac operation: comparison of membrane and bubble oxygenators. J Thorac Cardiovasc Surg 83:805–812PubMedGoogle Scholar
  9. 9.
    Harker LA, Malpass TW, Branson HE, Hessel EA 2nd, Slichter SJ (1980) Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. Blood 56:824–834PubMedGoogle Scholar
  10. 10.
    Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdick M, Selik NR, Wilson RF (1985) Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 11:281–292PubMedCrossRefGoogle Scholar
  11. 11.
    Gundry SR, Drongowski RA, Klein MD, Coran AG (1989) Postoperative bleeding in cardiovascular surgery. Does heparin rebound really exist? Am Surg 55:162–165PubMedGoogle Scholar
  12. 12.
    Tanaka K, Takao M, Yada I, Yuasa H, Kusagawa M, Deguchi K (1989) Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth 3:181–188PubMedCrossRefGoogle Scholar
  13. 13.
    Rinder CS, Bohnert J, Rinder HM, Mitchell J, Ault K, Hillman R (1991) Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 75:388–393PubMedCrossRefGoogle Scholar
  14. 14.
    Mengistu AM, Wolf MW, Boldt J, Rohm KD, Lang J, Piper SN (2008) Evaluation of a new platelet function analyzer in cardiac surgery: a comparison of modified thromboelastography and whole-blood aggregometry. J Cardiothorac Vasc Anesth 22:40–46PubMedCrossRefGoogle Scholar
  15. 15.
    Spiess BD, Tuman KJ, McCarthy RJ, DeLaria GA, Schillo R, Ivankovich AD (1987) Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 3:25–30PubMedCrossRefGoogle Scholar
  16. 16.
    Ti LK, Cheong KF, Chen FG (2002) Prediction of excessive bleeding after coronary artery bypass graft surgery: the influence of timing and heparinase on thromboelastography. J Cardiothorac Vasc Anesth 16:545–550PubMedCrossRefGoogle Scholar
  17. 17.
    Goodnough LT, Soegiarso RW, Birkmeyer JD, Welch HG (1993) Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery. Am J Med 94:509–514PubMedCrossRefGoogle Scholar
  18. 18.
    Nightingale CH, Robotti J, Deckers PJ, Allmendinger PD, Lowe R, Low HB (1987) Quality care and cost-effectiveness. An organized approach to problem solving. Arch Surg 122:451–456PubMedCrossRefGoogle Scholar
  19. 19.
    Spiess BD, Gillies BS, Chandler W, Verrier E (1995) Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 9:168–173PubMedCrossRefGoogle Scholar
  20. 20.
    Toth O, Calatzis A, Penz S, Losonczy H, Siess W (2006) Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 96:781–788PubMedGoogle Scholar
  21. 21.
    Calatzis A, Krueger WB (2004) A new approach to platelet function analysis in whole blood- the multiplate analyzer. Platelets 15:479–517CrossRefGoogle Scholar
  22. 22.
    Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA (2003) The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 96:51–57, table of contentsGoogle Scholar
  23. 23.
    Metz CE (1978) Basic principles of ROC analysis. Semin Nucl Med 8:283–298PubMedCrossRefGoogle Scholar
  24. 24.
    Paparella D, Brister SJ, Buchanan MR (2004) Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 30:1873–1881PubMedCrossRefGoogle Scholar
  25. 25.
    Harker LA (1987) Acquired disorders of platelet function. Ann NY Acad Sci 509:188–204PubMedCrossRefGoogle Scholar
  26. 26.
    Essell JH, Martin TJ, Salinas J, Thompson JM, Smith VC (1993) Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 7:410–415PubMedCrossRefGoogle Scholar
  27. 27.
    Forestier F, Coiffic A, Mouton C, Ekouevi D, Chene G, Janvier G (2002) Platelet function point-of-care tests in post-bypass cardiac surgery: are they relevant? Br J Anaesth 89:715–721PubMedCrossRefGoogle Scholar
  28. 28.
    Ray MJ, Marsh NA, Hawson GA (1994) Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Blood Coagul Fibrinolysis 5:679–685PubMedCrossRefGoogle Scholar
  29. 29.
    Nuttall GA, Oliver WC, Ereth MH, Santrach PJ (1997) Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 11:815–823PubMedCrossRefGoogle Scholar
  30. 30.
    Dorman BH, Spinale FG, Bailey MK, Kratz JM, Roy RC (1993) Identification of patients at risk for excessive blood loss during coronary artery bypass surgery: thromboelastography versus coagulation screen. Anesth Analg 76:694–700PubMedCrossRefGoogle Scholar
  31. 31.
    Wang JS, Lin CY, Hung WT, O’Connor MF, Thisted RA, Lee BK, Karp RB, Yang MW (1992) Thromboelastogram fails to predict postoperative hemorrhage in cardiac patients. Ann Thorac Surg 53:435–439PubMedCrossRefGoogle Scholar
  32. 32.
    Ostrowsky J, Foes J, Warchol M, Tsarovsky G, Blay J (2004) Plateletworks platelet function test compared to the thromboelastograph for prediction of postoperative outcomes. J Extra Corpor Technol 36:149–152PubMedGoogle Scholar
  33. 33.
    Royston D, von Kier S (2001) Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 86:575–578PubMedCrossRefGoogle Scholar
  34. 34.
    Reinhofer M, Brauer M, Franke U, Barz D, Marx G, Losche W (2008) The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 19:212–219PubMedCrossRefGoogle Scholar
  35. 35.
    Nielsen VG (2007) A comparison of the thrombelastograph and the TEM. Blood Coagul Fibrinolysis 18:247–252PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Mate Petricevic
    • 1
    • 6
  • Bojan Biocina
    • 1
  • Davor Milicic
    • 2
  • Sanja Konosic
    • 3
  • Lucija Svetina
    • 1
  • Ante Lekić
    • 1
  • Boris Zdilar
    • 4
  • Ivan Burcar
    • 1
  • Milan Milosevic
    • 5
  • Rifat Brahimaj
    • 1
  • Jure Samardzic
    • 2
  • Hrvoje Gasparovic
    • 1
  1. 1.Department of Cardiac SurgeryUniversity Hospital Center Zagreb, University of Zagreb School of MedicineZagrebCroatia
  2. 2.Department of Cardiovascular DiseasesUniversity Hospital Center Zagreb, University of Zagreb School of MedicineZagrebCroatia
  3. 3.Department of AnesthesiologyUniversity Hospital Center Zagreb, University of Zagreb School of MedicineZagrebCroatia
  4. 4.Department of SurgeryUniversity Hospital “Sveti Duh”ZagrebCroatia
  5. 5.Andrija Stampar School of Public HealthUniversity of Zagreb School of MedicineZagrebCroatia
  6. 6.Department of Cardiac SurgeryUniversity Hospital Rebro, ZagrebZagrebCroatia

Personalised recommendations